NCT06641076Phase 3Active not recruiting

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

Study sponsor: MoonLake Immunotherapeutics AG

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2027-02-04Estimated

Enrollment · participants960Estimated

Source updated2026-08-12Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-02-24 · 2 fields changed

Primary completion date changed

− Before

~~15 Jan 2027~~

+ After

4 Feb 2027

Recruitment status changed

− Before

~~Recruiting~~

+ After

Active not recruiting

Check registry source